Es gab 50 kürzliche Insider-Transaktionen für Black Diamond Therapeutics, Inc. (BDTX), darunter 46 Käufe und 2 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $7.14M und die gesamten Insider-Verkäufe auf $2.46M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Behbahani Ali, Raman Prakash, Hatzis-schoch Brent. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — BDTX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-20 |
Behbahani Ali |
Director |
RSU-Zuteilung |
6,919 |
$2.15 |
$14.88K |
93,568 |
| 2026-03-20 |
Raman Prakash |
Director |
RSU-Zuteilung |
6,105 |
$2.15 |
$13.13K |
37,132 |
| 2026-01-21 |
Hatzis-schoch Brent |
See Remarks |
RSU-Zuteilung |
250,000 |
$2.57 |
$642.5K |
250,000 |
| 2026-01-21 |
Yurasov Sergey |
Chief Medical Officer |
RSU-Zuteilung |
250,000 |
$2.57 |
$642.5K |
250,000 |
| 2026-01-21 |
Velleca Mark A. |
President & CEO |
RSU-Zuteilung |
600,000 |
$2.57 |
$1.54M |
600,000 |
| 2026-01-21 |
Buck Elizabeth |
Chief Scientific Officer |
RSU-Zuteilung |
250,000 |
$2.57 |
$642.5K |
250,000 |
| 2026-01-21 |
Jones Erika |
See Remarks |
RSU-Zuteilung |
200,000 |
$2.57 |
$514K |
200,000 |
| 2025-12-12 |
Behbahani Ali |
Director |
RSU-Zuteilung |
5,208 |
$2.76 |
$14.37K |
86,649 |
| 2025-12-12 |
Raman Prakash |
Director |
RSU-Zuteilung |
4,665 |
$2.76 |
$12.88K |
31,027 |
| 2025-09-19 |
Behbahani Ali |
Director |
RSU-Zuteilung |
4,291 |
$3.35 |
$14.37K |
81,441 |
| 2025-09-19 |
Raman Prakash |
Director |
RSU-Zuteilung |
3,843 |
$3.35 |
$12.87K |
26,362 |
| 2025-06-20 |
Behbahani Ali |
Director |
RSU-Zuteilung |
6,170 |
$2.33 |
$14.38K |
77,150 |
| 2025-06-20 |
Raman Prakash |
Director |
RSU-Zuteilung |
5,526 |
$2.33 |
$12.88K |
22,519 |
| 2025-06-12 |
Dhingra Kapil |
Director |
RSU-Zuteilung |
30,550 |
$2.43 |
$74.24K |
30,550 |
| 2025-06-12 |
Menzel Garry E |
Director |
RSU-Zuteilung |
30,550 |
$2.43 |
$74.24K |
30,550 |
| 2025-06-12 |
Behbahani Ali |
Director |
RSU-Zuteilung |
30,550 |
$2.43 |
$74.24K |
30,550 |
| 2025-06-12 |
Kulkarni Samarth |
Director |
RSU-Zuteilung |
30,550 |
$2.43 |
$74.24K |
30,550 |
| 2025-06-12 |
Raman Prakash |
Director |
RSU-Zuteilung |
30,550 |
$2.43 |
$74.24K |
30,550 |
| 2025-06-12 |
Campbell Shannon |
Director |
RSU-Zuteilung |
30,550 |
$2.43 |
$74.24K |
30,550 |
| 2025-03-21 |
Behbahani Ali |
Director |
RSU-Zuteilung |
7,646 |
$1.88 |
$14.37K |
70,980 |
| 2025-03-21 |
Raman Prakash |
Director |
RSU-Zuteilung |
6,848 |
$1.88 |
$12.87K |
16,993 |
| 2025-03-19 |
Biotech Growth N V |
10 Percent Owner |
Informierter Verkauf |
500,000 |
$2.12 |
$1.06M |
2,733,547 |
| 2025-01-30 |
Hatzis-schoch Brent |
See Remarks |
RSU-Zuteilung |
75,000 |
- |
- |
83,400 |
| 2025-01-30 |
Yurasov Sergey |
Chief Medical Officer |
RSU-Zuteilung |
75,000 |
- |
- |
75,000 |
| 2025-01-30 |
Velleca Mark A. |
President & CEO |
RSU-Zuteilung |
75,000 |
- |
- |
121,522 |
| 2025-01-30 |
Buck Elizabeth |
Chief Scientific Officer |
RSU-Zuteilung |
75,000 |
- |
- |
170,192 |
| 2025-01-30 |
Jones Erika |
See Remarks |
RSU-Zuteilung |
75,000 |
- |
- |
85,150 |
| 2024-12-13 |
Behbahani Ali |
Director |
RSU-Zuteilung |
5,750 |
$2.50 |
$14.38K |
63,334 |
| 2024-12-13 |
Raman Prakash |
Director |
RSU-Zuteilung |
5,150 |
$2.50 |
$12.88K |
10,145 |
| 2024-12-13 |
Campbell Shannon |
Director |
RSU-Zuteilung |
4,500 |
$2.50 |
$11.25K |
8,865 |
| 2024-09-20 |
Behbahani Ali |
Director |
RSU-Zuteilung |
3,007 |
$4.78 |
$14.37K |
57,584 |
| 2024-09-20 |
Raman Prakash |
Director |
RSU-Zuteilung |
2,694 |
$4.78 |
$12.88K |
4,995 |
| 2024-09-20 |
Campbell Shannon |
Director |
RSU-Zuteilung |
2,354 |
$4.78 |
$11.25K |
4,365 |
| 2024-08-28 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
Informierter Verkauf |
221,600 |
$6.32 |
$1.4M |
3,726,341 |
| 2024-06-21 |
Behbahani Ali |
Director |
RSU-Zuteilung |
2,887 |
$4.98 |
$14.38K |
54,577 |
| 2024-06-21 |
Raman Prakash |
Director |
RSU-Zuteilung |
2,301 |
$4.98 |
$11.46K |
2,301 |
| 2024-06-21 |
Campbell Shannon |
Director |
RSU-Zuteilung |
2,011 |
$4.98 |
$10.01K |
2,011 |
| 2024-06-06 |
Dhingra Kapil |
Director |
RSU-Zuteilung |
30,550 |
$4.65 |
$142.06K |
30,550 |
| 2024-06-06 |
Menzel Garry E |
Director |
RSU-Zuteilung |
30,550 |
$4.65 |
$142.06K |
30,550 |
| 2024-06-06 |
Behbahani Ali |
Director |
RSU-Zuteilung |
30,550 |
$4.65 |
$142.06K |
30,550 |
| 2024-06-06 |
Kulkarni Samarth |
Director |
RSU-Zuteilung |
30,550 |
$4.65 |
$142.06K |
30,550 |
| 2024-06-06 |
Raman Prakash |
Director |
RSU-Zuteilung |
30,550 |
$4.65 |
$142.06K |
30,550 |
| 2024-06-06 |
Campbell Shannon |
Director |
RSU-Zuteilung |
30,550 |
$4.65 |
$142.06K |
30,550 |
| 2024-04-10 |
Raman Prakash |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-04-10 |
Raman Prakash |
Director |
RSU-Zuteilung |
61,100 |
$4.98 |
$304.28K |
61,100 |
| 2024-04-10 |
Campbell Shannon |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-04-10 |
Campbell Shannon |
Director |
RSU-Zuteilung |
61,100 |
$4.98 |
$304.28K |
61,100 |
| 2024-03-15 |
Dixon Wendy L |
Director |
RSU-Zuteilung |
3,253 |
$4.54 |
$14.77K |
38,054 |
| 2024-03-15 |
Behbahani Ali |
Director |
RSU-Zuteilung |
3,166 |
$4.54 |
$14.37K |
51,690 |
| 2024-02-14 |
Hatzis-schoch Brent |
See Remarks |
RSU-Zuteilung |
200,000 |
$4.86 |
$972K |
200,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall